Kidney cancer (KC) ranks 14th in the most common cancers with 431,288 cases in 2020 and an estimated 179,368 deaths globally (1), with incidence on the rise. Clear cell renal cell carcinoma (ccRCC) is...
Read moreThe predictive power of VIGex in detecting those patients who are most likely to obtain clinical benefit from immunotherapy was initially validated in patients treated with ICIs in phase I immuno-onco...
Read moreAmong VHIO-led research that was selected by the American Society of Clinical Oncology (ASCO) to first outing during its 2022 Annual Meeting, 03 – 07 June, Chicago (IL, USA), two studies have report...
Read moreLa Unidad de Investigación de Terapia Molecular (UITM)-CaixaResearch tiene un papel destacado en el desarrollo de nuevos fármacos. Durante el Congreso Anual de la Sociedad Americana de Oncología Cl...
Read morePresented by Ana Oaknin, Principal Investigator of VHIO’s Gynecological Malignancies Group, during this week’s American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June 2022,...
Read morePublished in Cancer Research (2), a journal of the American Association for Cancer Research (AACR), research led by Joan Seoane, Co-Director of Preclinical and Translational Research at the Vall d’H...
Read moreLos linfocitos B activados por un antígeno son capaces de autoinfligirse alteraciones en el ADN para que la maquinaria de replicación celular se equivoque y surjan múltiples mutaciones. Naturalment...
Read moreNext-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger immune response compared to Pfizer-BioNTech’s Comirnaty booster vaccine
Read moreEl IMIM-Hospital del Mar apuesta por atraer talento científico de excelencia y jóvenes investigadores a través del IMIM-OpenLAB. La iniciativa pone a su disposición unas instalaciones completament...
Read moreExisten unos elementos provenientes de virus integrados en nuestro genoma -denominados retroelementos endógenos- que se encuentran en una forma inactiva, como silenciados. Con la activación de estos...
Read moreInvestigadores de la Unidad de Innovación Biomédica del CIEMAT/IIS-Fundación Jiménez Díaz y del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) han anunciado la publica...
Read moreThe study published in Clinical and Translational Medicine has shown that inflammation at the onset of the disease causes a change in astrocytes, a type of star-shaped cell of the central nervous syst...
Read more